| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/08/2004 | WO2003078614A3 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants |
| 01/08/2004 | WO2003074661A3 Cloning and characterization of a novel bk channel isoform highly expressed in glioma cells |
| 01/08/2004 | WO2003073106A3 Binding of pathological forms of prion proteins |
| 01/08/2004 | WO2003068812A3 Immune-modulating peptide made of s. aureus enterotoxin b |
| 01/08/2004 | WO2003067262A3 Methods and compositions involving the hsp90 activator aha1 |
| 01/08/2004 | WO2003063766A3 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/08/2004 | WO2003056294A8 Methods for identifying and using marr family polypeptide binding compounds |
| 01/08/2004 | WO2003054194A3 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 01/08/2004 | WO2003050302A3 Tgnp activity or expression as marker for apoptosis |
| 01/08/2004 | WO2003050238A3 Receptor-targeted adenoviral vectors |
| 01/08/2004 | WO2003050135A3 Use a parapox b2l protein to modify immune responses to administered antigens |
| 01/08/2004 | WO2003042233A3 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 01/08/2004 | WO2003020897A3 Compositions and methods relating to ovary specific genes and proteins |
| 01/08/2004 | WO2003020876A3 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 01/08/2004 | WO2003018827A3 Female-specific larval gene for insect control |
| 01/08/2004 | WO2003016505A3 Kgf polypeptide compositions |
| 01/08/2004 | WO2003013598A3 Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases |
| 01/08/2004 | WO2003007890A3 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002099036A3 Inhibition of neurodegeneration |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002095009A3 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer |
| 01/08/2004 | WO2002092765A3 Novel telomerase inhibitors and uses therefor |
| 01/08/2004 | WO2002092623A8 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF |
| 01/08/2004 | WO2002091996A3 Methods for treating cancer |
| 01/08/2004 | WO2002088313A3 Novel human nuclear transporters and polynucleotides encoding the same |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002078624A3 Aerosol administration of interleukin-2 liposomes |
| 01/08/2004 | WO2002072780A3 Igf antagonist peptides |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002064782A3 Rank ligand-binding polypeptides |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002055697A3 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | WO2002053594A3 Inhibitors of memapsin 2 and use thereof |
| 01/08/2004 | WO2002050250A3 Signal-1/signal-2 bifunctional peptide inhibitors |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | WO2002046225A3 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 01/08/2004 | WO2002046217A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/08/2004 | WO2002045743A3 Hcv vaccines |
| 01/08/2004 | WO2002044373A3 Adipocyte complement related protein zacrp12 |
| 01/08/2004 | WO2002038761A3 Regulation of human oat-like protein |
| 01/08/2004 | WO2002038613A3 Modified recombinase |
| 01/08/2004 | WO2002034776A3 Epitopes of pai-1 |
| 01/08/2004 | WO2002008265A3 Staphylococcus aureus ribosomal protein s20, corresponding gene and methods for the identification of antibacterial substances |
| 01/08/2004 | WO2002006345A3 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 01/08/2004 | US20040006797 Comprises expression vector coding root hair regulatory protein for generating and propagating plants and seeds with improved yields, drought tolerance and/or elevated seed oil concentrations |
| 01/08/2004 | US20040006796 Methods of modulating cytokinin related processes in a plant using B3 domain proteins |
| 01/08/2004 | US20040006795 Increasing flavonoid production in soy bean plants; food processing; nutrients; beverages |
| 01/08/2004 | US20040006794 Bioengineering cotton fiber properties |
| 01/08/2004 | US20040006793 Novel regulatory genes involved in condensed tannin synthesis in plants |
| 01/08/2004 | US20040006789 Pseudomonas syringae harpins, HopPtoP and HopPmaHpto, and their uses |
| 01/08/2004 | US20040006788 Procedures and materials for conferring disease resistance in plants |
| 01/08/2004 | US20040006786 Novel glycine-rich gene |
| 01/08/2004 | US20040006785 For controlling flea beetles of the genus Phyllotreta |
| 01/08/2004 | US20040006783 Comprises nucleotide sequences coding a guanosine triphosphatase with a cyclin dependent kinase rac-interactive binding (CRIB) motif for generating transgenic plants with improved growth in decreased oxygen |
| 01/08/2004 | US20040006782 Non-human mammal mutant for expression of the alpha6 subunit of the nicotinic acetylcholine receptor, and use for screening substances that can interact with said receptor |
| 01/08/2004 | US20040006780 VEGF-modulated genes and methods employing them |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |
| 01/08/2004 | US20040006778 Comprises heat resistant polypeptide for preparing pharmaceuticals; drug biosynthesis; side effect reduction |
| 01/08/2004 | US20040006775 Invention provides mice having reduced constitutive androstane receptor activity and mice expressing a human CAR receptor |
| 01/08/2004 | US20040006219 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006218 Comprises nucleotide sequences coding microorganismal envelop proteins for vaccine development, diagnosis and infection prevention; immunotherapy; bactericides |
| 01/08/2004 | US20040006217 Comprises coagulation factor VIIa/VII receptor for treatment and prevention of thrombosis, septic shock and adult respiratory distress syndrome (ARDS); anticoagulants; thrombolytic agents |
| 01/08/2004 | US20040006211 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006210 Human polyhomeotic 2 (hph2) acts as an oncogene |
| 01/08/2004 | US20040006209 Comprises immunoglobulin which specifically binds staphylococcal g-protein and receptor sites for preventing and treating infections; gentic vaccines |
| 01/08/2004 | US20040006208 Comprises three-dimensional structure of bound immunoglobulin complex; antiinflammatory/anticarcinogenic; viricides |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006206 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/08/2004 | US20040006205 Comprises g-protein coupled receptor polypeptides for diagnosis, prevention and treatment of cancers, infections and dyslipidemias |
| 01/08/2004 | US20040006204 Preparing amino acid sequences associated with fatty acid binding proteins (FABP); mimetics; parasitides; genetic vaccines for preventing schiostosoma and/or fasciola infections; veterinary medicines |
| 01/08/2004 | US20040006202 Comprises tyrosine phosphatase peptides for diagnosis, prevention and treatment of autoimmune diseases; immunotherapy |
| 01/08/2004 | US20040006144 Unit dosage form for oral administration; therapy |
| 01/08/2004 | US20040006129 Administering compound selected from 4,4'-(isopropylidenedithio) bis(2,6-di-tert-butylphenol), 2,3-Dihydro-5-hydroxy-2 2-dipentyl-4,6-di-tert-butyl-benzofuran, vitamin E and vitamin c |
| 01/08/2004 | US20040006093 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/08/2004 | US20040006037 Flagellin gene, flaC of Campylobacter |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/08/2004 | US20040006019 Methods for transporting vitamin C transporter and related methods |
| 01/08/2004 | US20040006011 Peptidomimetic modulators of cell adhesion |
| 01/08/2004 | US20040006008 Localize to a specific subcellular compartment such as the lysosome are provided. The targeted therapeutics include a therapeutic agent and a targeting moiety that binds a receptor on an exterior surface of the cell, permitting proper |
| 01/08/2004 | US20040006006 Polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the |
| 01/08/2004 | US20040006001 Ferritin fusion proteins for use in vaccines and other applications |
| 01/08/2004 | US20040005711 Alphaviral vector system comprising papilloma viral orgin of replication and antitumor agent for prevention and treatment urogenital cancer; gene therapy |
| 01/08/2004 | US20040005708 For gene therapy, transferring therapeutic genes into cells |
| 01/08/2004 | US20040005693 Propagating and extracting reovirus from human embryonic kidney cells; ion exchange chromatography |
| 01/08/2004 | US20040005689 Three dimensional model of acute myeloid leukemia protein (AML-1) comprising runt domain for treating and preventing diseases associated with chromosomal translocations; genetic mapping |
| 01/08/2004 | US20040005684 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 01/08/2004 | US20040005682 Biocidal protein |
| 01/08/2004 | US20040005671 Immunointeractive molecules |
| 01/08/2004 | US20040005670 Compositions and methods for the treatment of hemophilia A |
| 01/08/2004 | US20040005669 Multimeric polypeptide for treating diabetes |
| 01/08/2004 | US20040005668 Production of human parathyroid hormone from microorganisms |
| 01/08/2004 | US20040005667 Comprises protein for developing vaccines which prevent chlamydial infections; genetic vaccines |
| 01/08/2004 | US20040005666 Methods and reagents for modulating cholesterol levels |
| 01/08/2004 | US20040005665 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, tumorous and nervous system disorders |
| 01/08/2004 | US20040005663 Mixture comprising genetically engineered swine proteins for treating and preventing bone and skin disorders; bioreactors |
| 01/08/2004 | US20040005662 Culuring transgenic cells which codes bactericides; genetic vaccines |